Skip to main content

Table 2 E2 targeted genes from RT2 Profiler™ PCR array human tumor metastasis compared between E2-treated KKU-213 and untreated control

From: Increased ETV4 expression correlates with estrogen-enhanced proliferation and invasiveness of cholangiocarcinoma cells

Genes

Full name

Fold change

Up-regulated gene

 ITG B3

Integrin, beta 3 (platelet glycoprotein IIIa, antigen CD61)

15.81

 MET

Met proto-oncogene (hepatocyte growth factor receptor)

7.38

 MMP11

Matrix metallopeptidase 11 (stromelysin 3)

6.27

 HPSE

Heparanase

5.87

 HRAS

V-Ha-ras Harvey rat sarcoma viral oncogene homolog

5.36

 SYK

Spleen tyrosine kinase

4.49

 IL18

Interleukin 18 (interferon-gamma-inducing factor)

4.16

 CXCR4

Chemokine (C-X-C motif) receptor 4

3.98

 RPSA

Ribosomal protein SA

3.43

 IL1B

Interleukin 1, beta

3.32

 FGFR4

Fibroblast growth factor receptor 4

2.89

 DENR

Density-regulated protein

2.56

 ETV4

ETS variant 4

2.49

 MMP10

Matrix metallopeptidase 10 (stromelysin 2)

2.16

Down-regulated gene

 CTBP1

C-terminal binding protein 1

0.42

 RORB

RAR-related orphan receptor B

0.41

 FAT

FAT tumor suppressor homolog 1 (Drosophila)

0.39

 BRMS1

Breast cancer metastasis suppressor 1

0.34

 CST7

Cystatin F (leukocystatin)

0.24

 CD82

CD82 molecule

0.20

 TNFS10

Tumor necrosis factor (ligand) superfamily, member 10

0.16

 RB1

Retinoblastoma 1 (including osteosarcoma)

0.13

 TRPM1

Transient receptor potential cation channel, subfamily M, member 1

0.12

  1. Among a total of 84 genes analyzed, the relative expression of 14 genes was up-regulated (by more than twofold) in response to estrogen, while 9 genes were downregulated (by less than 0.5-fold)